Withdrawal statement
The authors have withdrawn this manuscript due to a duplicate posting of manuscript number MEDRXIV/2026/364225. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author. The correct preprint can be found at doi: 10.64898/2026.09.28.26364225.
Competing Interest Statement
CLR, DT, LL, RJY, and MK are partners in Cambridge Prediction Analytics.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study analyzed de-identified human subject data obtained from Celeri Health. Data access and usage were governed by a formal data use agreement between Celeri Health and Cambridge Prediction Analytics, ensuring compliance with all applicable data privacy and security regulations. No new human data were collected, and no identifiable private information was accessed or analyzed. In accordance with U.S. federal regulations (45 CFR 46) and the principles of the Declaration of Helsinki, this secondary analysis does not constitute human subjects research and did not require institutional review board (IRB) approval.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes





